Recently Viewed 0
Meet Clearsynth at CPHI Milan · October 6–8, 2026 · Booth 10F24 Book a meeting
My Account Need quick assistance? WhatsApp us +91-22-45045900 sales@clearsynth.com
Home Tamoxifen Impurity CS-O-16930

tamoxifen citrate impurity B

Enquire

tamoxifen citrate impurity B

Impurity · API Family: Tamoxifen · CAT No. CS-O-16930 · CAS No. 748-97-0
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Clearsynth product packaging

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.

tamoxifen citrate impurity B Product Information

tamoxifen citrate impurity B is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Tamoxifen. The product is supplied by Clearsynth under CAT No. CS-O-16930.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name
tamoxifen citrate impurity B
CAS No.
748-97-0
CAT No.
CS-O-16930
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C26H31NO2
Molecular Weight
389.5
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.

Description

Regulatory Description
tamoxifen citrate impurity B is supplied with detailed characterization data compliant with regulatory guideline. tamoxifen citrate impurity B can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tamoxifen.
Overview
(�)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol is an impurity of Tamoxifen (T006000); a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor.
Synonyms
tamoxifen citrate impurity B
Application Notes
(�)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol is an impurity of Tamoxifen (T006000); a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor.
References

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Buy 748-97-0Purchase 748-97-0Order 748-97-0Enquire 748-97-0Price of 748-97-0748-97-0 Supplier748-97-0 Manufacturer748-97-0 ExporterBuy high quality tamoxifen citrate impurity BPurchase tamoxifen citrate impurity Btamoxifen citrate impurity B Supplierstamoxifen citrate impurity B Manufacturerstamoxifen citrate impurity B PriceOrder tamoxifen citrate impurity BEnquire tamoxifen citrate impurity Btamoxifen citrate impurity B Costtamoxifen citrate impurity B Suppliertamoxifen citrate impurity B Distributortamoxifen citrate impurity B for Method Validationtamoxifen citrate impurity B for ANDA Filingtamoxifen citrate impurity B for Forced Degradation Studiestamoxifen citrate impurity B Identification Standardstamoxifen citrate impurity B for DMF FilingTamoxifen Reference Standard
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.